ROYAL BANK OF CANADA - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M601. A total of 37 filers reported holding ACORDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$0329
+1.9%
0.00%
Q4 2022$0323
-4.2%
0.00%
Q3 2022$0337
+15.0%
0.00%
Q2 2022$0293
-12.8%
0.00%
Q1 2022$0
-100.0%
336
-62.5%
0.00%
Q4 2021$3,000
+200.0%
895
+256.6%
0.00%
Q3 2021$1,000
-50.0%
251
-43.6%
0.00%
Q2 2021$2,000
-60.0%
445
-58.6%
0.00%
Q1 2021$5,0001,0760.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 649,031$1,045,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 244,090$393,0000.01%
United Asset Strategies, Inc. 27,100$44,0000.01%
Saltoro Capital, LP 14,848$24,0000.01%
ACADIAN ASSET MANAGEMENT LLC 467,739$751,0000.00%
Point72 Asset Management, L.P. 464,276$747,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 22,600$36,0000.00%
Renaissance Technologies 707,218$1,139,0000.00%
Russell Investments Group, Ltd. 6,000$9,0000.00%
FIRST MANHATTAN CO. LLC. 50$00.00%
View complete list of ACORDA THERAPEUTICS INC shareholders